價(jià)格 | ¥346 | ¥825 | ¥1260 |
包裝 | 1mg | 5mg | 10mg |
最小起訂量 | 1mg |
發(fā)貨地 | 上海 |
更新日期 | 2024-12-12 |
中文名稱:化合物 CW069 | 英文名稱:CW-069 |
CAS:1594094-64-0 | 品牌: TargetMol |
產(chǎn)地: 美國(guó) | 保存條件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
純度規(guī)格: 98.59% | 產(chǎn)品類別: 抑制劑 |
貨號(hào): T6209 |
名稱 | CW-069 |
描述 | CW-069 (IC50=75 μM), an allosteric selective inhibitor of microtubule motor protein HSET, exhibits remarkable specificity over KSP. |
細(xì)胞實(shí)驗(yàn) | Cells are cultured in DMEM supplemented with 10% fetal calf serum (FCS) at 37°C and 5% CO2. All compounds used in the Sulforhodamine B colorimetric (SRB) assay are dissolved in DMSO and diluted in culture medium to a final concentration of 0.2% DMSO. For the SRB assay and live-cell imaging, cells are seeded in 96-well plates at a density of 2,500 cells per well. After 24 hr, the cells are treated with compound for 72 hr, with triplicate wells for each concentration. For the SRB assay, the cells are then fixed with trichloroacetic acid (TCA) and stained with SRB. Fluorescence is quantified using an Infinite 200 PRO plate-reader at a wavelength of 545 nm. Compound-treated wells are compared with solvent control wells and the concentration of compound that results in 50% of the solvent-control cell growth is designated as the IC50 concentration, calculated using Graphpad PRISM 6. At least three biological replicates are performed for each assay.(Only for Reference) |
激酶實(shí)驗(yàn) | In Vitro Enzymatic ATPase Assay: The protocol is optimized for use with full-length, N-terminal, 6His-tagged HSET and KSP, and measured the MT-stimulated activity of the proteins. Inhibition of the Gsp synthetase activity of HSET/KSP is observed spectrophotometrically by coupling the hydrolysis of ATP to oxidation of NADH via pyruvate kinase/lactate dehydrogenase reactions. The assay is initiated by adding purified Gsp synthetase/amidase (12.8 nM) to an assay mixture containing the following components (final concentration): 6 nM protein, 0.07 mg/ml MTs (University Biologicals), 1.56 mM glutathione, 10 mM spermidine, 2 mM ATP, 2.7 mM MgCl2, 1 mM phospho(enol)-pyruvate, 0.2 mM NADH, 50 μg/ml lactate dehydrogenase, 100 μg/ml pyruvate kinase, and various concentrations of inhibitor all in 50 mM Na PIPES (pH 6.8) at 37°C. The ADP-Glo detection assay (Promega) is performed as described in the manufacturer's instructions. All compound additions were performed using a multidrop BioMek Nxp. Plates were read using a Pherastar microplate reader. |
體外活性 | CW069在具有多余中心體的N1E-115細(xì)胞中增加多極紡錘體,但不改變正常人類真皮成纖維細(xì)胞的雙極紡錘體形態(tài)。同時(shí),CW069對(duì)N1E-115癌細(xì)胞的生長(zhǎng)具有抑制作用,IC50為10 μM。[1] |
存儲(chǔ)條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度 | Ethanol : 4 mg/mL (7.99 mM) DMSO : 93 mg/mL (185.9 mM) H2O : < 1 mg/mL (insoluble or slightly soluble) |
關(guān)鍵字 | CW 069 | Inhibitor | Kinesin | inhibit | CW-069 |
相關(guān)產(chǎn)品 | 4-Isopropoxybenzoic acid | Docetaxel | Mebendazole | Flubendazole | Oxfendazole | Methylene Blue | Thiabendazole | Methylene Blue trihydrate | Griseofulvin | N-Phenylbenzylamine | Paclitaxel | 4'-Demethylepipodophyllotoxin |
相關(guān)庫 | 抑制劑庫 | 抗癌活性化合物庫 | 經(jīng)典已知活性庫 | 抗癌化合物庫 | 已知活性化合物庫 | 細(xì)胞骨架化合物庫 | NO PAINS 化合物庫 | 微管靶向化合物庫 | 內(nèi)質(zhì)網(wǎng)應(yīng)激化合物庫 |
成立日期 | 2013-04-18 (12年) | 注冊(cè)資本 | 566.265100萬人民幣 |
員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1億以上 |
主營(yíng)行業(yè) | 天然產(chǎn)物,生化試劑,分子生物學(xué),分子砌塊,生物技術(shù)服務(wù) | 經(jīng)營(yíng)模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
---|---|---|---|---|
詢價(jià) |
VIP6年
|
上海澤葉生物科技有限公司
|
2025-02-12 | |
詢價(jià) |
VIP3年
|
河南威梯?;た萍加邢薰?/div>
|
2025-02-11 | |
¥228.90 |
VIP2年
|
上海阿拉丁生化科技股份有限公司
|
2024-11-29 |